Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson Won't Blow Out Earnings But Still Worth $72.50
Forbes
Mon, 04/16/12 - 11:28 am
Tags:
JNJ, earnings
How Does Johnson & Johnson Boost Its Returns?
Motley Fool
Sun, 04/15/12 - 12:31 pm
Tags:
JNJ
J&J’s Gorsky Should Be Forced to Testify in Suit, U.S. Says
Bloomberg
Sat, 04/14/12 - 12:33 pm
Tags:
JNJ, Alex Gorsky, legal, lawsuit
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Fri, 04/13/12 - 08:29 am
Tags:
Dendreon, Provenge, JNJ, Medivation, prostate cancer, Immunogen, Seattle Genetics
Johnson & Johnson Worst Days May Be Ahead Of It
Seeking Alpha
Thu, 04/12/12 - 12:27 pm
Tags:
JNJ
Johnson & Johnson First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thu, 04/12/12 - 11:27 am
Tags:
earnings, JNJ
Arkansas judge fines J&J $1.1B in Risperdal case
Yahoo/AP
Wed, 04/11/12 - 12:00 pm
Tags:
JNJ, fines, Risperdal
J&J’s Marketing of Risperdal Violated Law, Arkansas Jury Rules
Bloomberg
Wed, 04/11/12 - 09:31 am
Tags:
Arkansas, JNJ, Risperdal
J&J looks for workaround to ease Doxil shortage
Fierce Pharma
Tue, 04/10/12 - 11:36 am
Tags:
Doxil, drug shortages, JNJ
Dendreon: Healthy Competition Will Boost Profits
Seeking Alpha
Tue, 04/10/12 - 11:15 am
Tags:
Dendreon, Provenge, prostate cancer, Abbott Laboratories, Bristol-Myers Squibb, JNJ, Sanofi
Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Yahoo/AP
Tue, 04/10/12 - 09:31 am
Tags:
JNJ, Risperdal, Arkansas, Janssen
4 Pharmaceuticals That Could Plummet This Year
Seeking Alpha
Tue, 04/10/12 - 09:26 am
Tags:
Pfizer, Abbott Laboratories, JNJ, Angiotech
Johnson & Johnson: Valuing The Dividends
Seeking Alpha
Mon, 04/9/12 - 01:03 pm
Tags:
dividends, JNJ
Vertex Pharmaceuticals Could See Strong Gains From Incivek
Seeking Alpha
Mon, 04/9/12 - 12:15 pm
Tags:
Incivek, Vertex Pharmaceuticals, Dendreon, JNJ, hepatitis C, Achillion
4 Biotech Stocks Outperforming Vertex
Seeking Alpha
Mon, 04/9/12 - 12:08 pm
Tags:
Vertex Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb, Gilead, JNJ
Vivus: Ready To Gain From Qnexa
Seeking Alpha
Mon, 04/9/12 - 11:57 am
Tags:
Vivus, Qnexa, obesity, JNJ, Novartis, Pfizer, Teva Pharmaceuticals
Is Johnson & Johnson a Cash King?
Motley Fool
Sun, 04/8/12 - 12:29 pm
Tags:
JNJ
'Animal rule' allowed for J&J drug backed for new approval
Fierce Pharma
Thu, 04/5/12 - 09:18 pm
Tags:
JNJ, Levaquin, antibiotics
Expensive Celgene Shares A Better Bet Than Most Biotechs
Seeking Alpha
Thu, 04/5/12 - 09:10 pm
Tags:
Celgene, JNJ, ONYX Pharmaceuticals, Revlimid, Pfizer
FDA's Expanded Intelence Approval Will Boost JNJ's Anti-Infectives Business
Forbes
Wed, 04/4/12 - 08:29 am
Tags:
FDA, Intelence, anti-infectives, JNJ, non-nucleoside reverse transcriptase inhibitor

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.